Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients (Q44314310)
Jump to navigation
Jump to search
scientific article published on 15 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients |
scientific article published on 15 June 2013 |
Statements
1 reference
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients (English)
1 reference
Laura Rosiñol
1 reference
Teresa Caballero-Velázquez
1 reference
Lucia López-Corral
1 reference
Cristina Encinas
1 reference
Cristina Castilla-Llorente
1 reference
Rodrigo Martino
1 reference
Antonia Sampol
1 reference
Dolores Caballero
1 reference
David Serrano
1 reference
Inmaculada Heras
1 reference
Jesús San Miguel
1 reference
José A Pérez-Simón
1 reference
15 June 2013
1 reference
1 reference
162
1 reference
4
1 reference
474-482
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference